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Abstract
Background
As Malawi continues to suffer from a large burden of  noncommunicable diseases (NCDs), models for NCD screening need to be 
developed that do not overload a health system that is already heavily burdened by communicable diseases.
Methods
This descriptive study examined 3 screening programmes for NCDs in Neno, Malawi, that were implemented from June 2015 to 
December 2016. The NCD screening models were integrated into existing platforms, utilising regular mass screening events in the 
community, patients awaiting to be seen in a combined NCD and HIV clinic, and patients awaiting treatment at outpatient departments 
(OPDs). Focusing on hypertension and diabetes, we screened all adults 30 years and above for hypertension using a single blood pressure 
cut-off  of  160/110 mmHg, as well as adults 40 years and above for diabetes, measuring either random blood sugar (RBS) or fasting 
blood sugar (FBS), with referral criteria of  FBS > 126 mg/dL and RBS > 200 mg/dL. Data were collected on specifically designed 
screening registers, then entered and analysed in Excel.
Results
Over 14,000 adults (≥ 12 years old) were screened for an array of  common conditions at community screening events. Of  these adults, 
58% (n = 8133) and 29% (n = 4016) were screened for hypertension and diabetes, respectively. Nine percent (n = 716) and 3% ( n = 113) 
were referred for further hypertension and diabetes assessment respectively. At one OPD, 5818 patients (60%) had their blood pressures 
measured, and among adults 30 years and above, 168 eligible adults were referred for further hypertension assessment. Since the initiation 
of  the screening programmes, the number of  patients ever enrolled for NCD care every 3 months has nearly tripled, from 40 to 114.
Conclusions
The screening models have shown that it is not only feasible to introduce NCD screening into a public system, but screening may have 
also contributed to increased enrolment in NCD care in Neno, Malawi.
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Introduction
Chronic noncommunicable diseases (NCDs) contribute 
to nearly 70% of  all deaths globally.1 In 2015, about 39.8 
million deaths from chronic NCDs occurred worldwide—a 
14% increase from 2005.2 The NCD burden is projected 
to further increase over the next decade, with estimated 
NCD deaths rising to 52 million by 2030.1 Cardiovascular 
diseases (CVDs) contribute to nearly half  of  all NCD deaths 
worldwide.2
The major burden of  chronic NCDs occurs in low- and 
middle-income countries, where over two-thirds of  NCD 
deaths are reported.1 In Africa, rates of  CVDs and their risk 
factors vary across countries, although data are still sparse 
due to a lack of  NCD reporting systems and minimal chronic 
NCD research.3 However, it is known that hypertension rates 
vary from 6% to 48%, diabetes from 0% to 16%, and stroke 
from 0.07% to 0.3%.4 Malawi, one of  sub-Saharan Africa’s 
poorest countries, is estimated to have prevalence rates of  up 
to 33% and 6% for hypertension and diabetes, respectively, 
in adults aged 25 to 64 years.5 NCDs are considered among 
the leading causes of  death, second only to HIV/AIDS,6 
and a recent study on inpatients in Malawi found that, while 
infections remain the leading cause of  adult admission, 
NCDs were the most frequent causes of  death in adults over 
55 years old.7 The high burden of  NCDs in Africa presents 
challenges to providing NCD care, as these countries also 
have a huge burden of  communicable diseases, notably 
HIV/AIDS and its complications. 
Despite the devastating burden of  infectious diseases in 
Malawi, NCD care was included in Health Sector Strategic 
Planning (HSSP) for 2011–2016, which was closely followed 
by the National NCD Action Plan (NAP) for 2012–2016.8 
Through these crucial documents, the government of  Malawi 
committed to providing essential care for common NCDs—
including CVDs, cancers, epilepsy, mental health, and 
injuries and trauma. The government of  Malawi proposed 
to provide the entire spectrum of  care along the NCD care 
pathway: primary prevention of  risk factors, screening, 
treatment and follow-up, and monitoring and evaluation for 
common chronic NCDs.6,9 
Screening for NCDs, especially CVDs, provides the first 
entry to NCD diagnosis and care. Despite screening being 
recognised as the entry to care, routine NCD screening 
at community and health facilities has, historically, been 
deemed not feasible in Africa due to a lack of  capacity within 
health systems.10 As screening programmes are rolled out 
in other settings and for other conditions in Africa, NCD 
screening integration with existing screening services has 
been advocated.10 However, limited data exist in Malawi on 
the feasibility of  screening programmes for common NCDs, 
especially CVDs.
We present 3 screening models that have been used 
successfully as part of  clinical care in Neno, Malawi, 
following a trend of  integrated care at the service delivery 
level.11 We describe the screening models, results of  the 
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established at Lisungwi Community Hospital in 2013. These 
clinics treated common NCDs, such as hypertension, asthma, 
epilepsy, diabetes, and congestive heart failure.13 However, in 
an effort to decentralise NCD care even further, the Chronic 
Care Clinics were integrated with HIV clinics to form the 
Integrated Chronic Care Clinic—locally known as IC3, or 
“Ice-Cubed”—in January 2015. The purpose of  integration 
was to allow for decentralisation of  NCD care to all health 
facilities, thus leveraging the strong platform of  HIV care 
whilst allowing patients with NCD and HIV dual diagnoses 
to receive care in single combined visits. Before integration, 
HIV care was fully decentralised in all health facilities and 
over 6800 HIV patients were receiving care in Neno as of  
December 2014. After the formation of  IC3 in 2015, NCD 
care was also decentralised to all health facilities. Currently, 
patients with HIV, epilepsy, heart failure, hypertension, 
diabetes, and mental illness are all managed at IC3 at the 2 
hospitals and 12 health centres in the district. Wroe et al. 
previously described the implementation of  IC3 in Neno.11 
Despite a functioning IC3 clinic, we had persistent under-
enrolment in NCD care in a system with limited resources 
available to screen for NCDs.
Before the initiation of  IC3 and the screening programmes 
implemented shortly thereafter, very few patients in Neno 
were enrolled in care in comparison to the expected number 
of  NCD patients. For example, if  we accept the national 
prevalence estimates of  33% and 6% for hypertension and 
diabetes from the 2009 STEPS survey, then it would be 
expected that the clinics in Neno should have enrolments 
of  close to 24,000 and 4,500 individuals with hypertension 
and diabetes, respectively. However, in December 2014, 
only 501 (representing 0.33% of  Neno’s population) and 
66 (representing 0.044%) had ever been enrolled in the 2 
hospital-based chronic care clinics with primary diagnoses 
of  hypertension or diabetes, respectively. 
While we understood that NCDs were under-represented 
among patients enrolled in longitudinal care in Neno 
District, we did not have the resources to implement parallel 
NCD programmes to our pre-existing services. Therefore, 
while our goal was to increase case detection and enrolment 
in NCD care, it was to do so within the constraints of  the 
existing health system and with limited resources. 
Neno NCD screening programmes
We designed 3 screening programmes aimed at increasing 
case detection for NCDs: in the community, at the facility for 
acute outpatient care, and at IC3 itself  (Table 1). The SHARC 
(Screening for Health and Referral in the Community) 
programme started as a community pilot in 2 catchment 
areas in February 2015, and then was scaled across the district 
in July 2015. During these community events, support staff  
screened all eligible individuals who wanted to be screened 
for one or more conditions, including HIV, TB, diabetes, 
hypertension, and nutritional disorders. A clinician was 
responsible for the final decision of  whether or not to refer 
the patient to his or her nearest health facility. The facility 
counterpart, SHARF (Screening for Health and Referral at 
the Facility), offered all patients presenting to an outpatient 
department (OPD) the opportunity to be screened for the 
same set of  conditions, as well as cervical cancer. Despite vital 
sign measurements, such as blood pressure, being a norm 
in developed countries and many private clinics in Malawi, 
most public facilities do not routinely measure vital signs.10 
Therefore, we utilised patient waiting time in the OPD to 
screening programmes to date, and introduce lessons learnt 
from initiating these models in Neno district. We focus on 
multi-disease screening programmes that target nutritional 
disorders, hypertension, diabetes, HIV, tuberculosis (TB), 
and cervical cancer, but for the purpose of  this descriptive 
paper we present data on hypertension and diabetes patients 
only. We hope that this adds to the growing evidence base 
on how to launch screening programmes for NCDs in rural 
areas of  Malawi. 
Methods
Study type
The was a descriptive study describing NCD screening 
programmes in the community and health facilities of  Neno 
District, Malawi, between June 2015 and December 2016.
Setting 
Partners In Health (PIH) has been working with the Ministry 
of  Health (MOH) in Neno since 2007. Neno District is in the 
Southern Region of  Malawi and had a estimated population 
of  over 158,000 in 2016.12 The district has 2 hospitals 
and 12 health facilities (Figure 1). Access to essential care 
remains a challenge due to poverty and poor accessibility of  
health services. In Neno, about 65% of  people live below 
the poverty line (15% higher than national average), and 
about 23% of  the population have limited access to health 
facilities.13,14 By implementing these models of  multi-disease 
screening, we hope to expand access to care within Neno, 
and show that integrating NCD care into communicable 
disease programmes can help increase and improve service 
delivery without introducing considerable strain on the 
existing health system. 
In 2009, PIH and the MOH began the Neno Chronic Care 
Clinic based at Neno District Hospital. This clinic was further 
Figure 1: Map of Neno District, Malawi, showing locations of 
health facilities 
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provide targeted screening. 
In both these programmes, 
all individuals with positive 
screening result for NCDs 
were referred to IC3. At IC3 
itself, we utilised patient 
waiting time to provide 
screening for enrolled 
patients. We trained existing 
IC3 clerks and expert clients 
to assess eligible patients 
and perform anthropometric 
measurements, blood 
sugar, and blood pressure. 
All patients who did not 
know their HIV status were 
referred to a counsellor for 
an HIV test, and all suspected 
TB patients were requested 
to submit sputum. Abnormal 
results prompted referral to 
an IC3 clinician for a review 
of  these results at the same 
time that they were seen for 
their primary diagnosis. This 
additional NCD screening 
was all completed within 
the existing structure and 
workflow of  IC3, allowing 
for additional screening 
without adding any extra 
space or staff.
These 3 screening 
programmes were founded 
on 4 basic principles. First, 
NCD screening should 
mirror current screening 
practices—we developed screening programmes for NCDs 
based on existing screening platforms in Neno, such as 
HIV and nutrition. Second, NCD screening should be 
integrated with other disease screening. This allowed the 
use of  resources—such as vehicles, fuel, and staff  time—
directed to these programmes to be used for NCD screening 
as well. Third, task shifting should be introduced to allow for 
efficiency and reduce staffing costs. All disease screening is 
done by support staff  with only 1 or 2 clinicians or nurses 
supporting the team. Task shifting enabled multi-disease 
screening to be feasible, as the district healthcare workers 
were too few to support all the activities of  the screening 
programmes. Finally, all eligible individuals should be offered 
screening. By offering screening for more diseases to all 
patients, we hoped to ensure that more patients were brought 
into care and commenced on treatment where necessary.
Screening  protocols and guidelines across screening 
programmes
We developed standardised guidelines for identifying eligible 
patients, conducting screening, capturing data, and referring 
patients in the 3 screening programmes. For hypertension, 
we screened all adults aged 30 years and older using a cut-off  
of  170/110 mmHg, in order to not overwhelm the newly 
decentralised IC3 clinics and to identify the highest risk 
patients. We then reduced this threshold to 160/110 mmHg 
to capture more hypertensive patients. For clients with 
blood pressures between 140 and 159 mmHg (systolic), and 
90 and 109 mmHg (diastolic), we provided education and 
encouraged a blood pressure re-check after 1 week at their 
nearest facility. For diabetes, we measured adults 40 years and 
older for either random blood sugar (RBS) if  they had eaten 
in the previous 8 hours or fasting blood sugar (FBS) if  they 
had not eaten in the previous 8 hours. Referral criteria for 
diabetic patients was FBS > 126 mg/dL and RBS > 200mg/
dL. We excluded patients who were known hypertensive or 
diabetic or already enrolled in our IC3 clinics with diagnoses 
of  hypertension or diabetes. We standardised hypertension 
and diabetes protocols across the 3 screening programmes.
For referral, all clients with a positive screening for high 
blood pressure or abnormal sugar at SHARF and SHARC 
were given a referral slip and referred to the nearest 
health facility on an IC3 clinic day. At the clinic, 2 or more 
confirmatory blood pressure tests and fasting blood glucose 
tests were expected to be done and, if  a clinician confirmed 
the diagnosis, the patient was enrolled in NCD care. If  
screening was done at IC3, they were seen on the same day 
by clinical staff. 
We provided a training orientation of  the protocols and 
guidelines to all support staff  involved in the screening 
programmes. The training was provided to hospital 
attendants, expert clients, and HIV testing counsellors. 
Ongoing mentorship is provided by clinicians and nurses 
involved in all 3 screening programmes. 
Table 1: Models of noncommunicable disease (NCD) screening in Neno
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this period, 2311 and 12 same-day referrals were made for 
hypertension and diabetes, respectively. 
Enrolment in IC3 for hypertension and diabetes
Since the initiation of  the 3 screening programmes, we saw 
an increase in the number of  patients with NCDs enrolled 
in care through IC3. Between October 2013 and March 
2015, before start of  our integrated screening programmes, 
we enrolled a mean of  40 new hypertensive patients per 
3-month quarter. After implementing these integrated 
screening programmes between April 2015 and March 2016, 
we enrolled an mean of  128 new hypertension clients per 
3-month quarter (Figure 2).
Discussion
Our experience suggests that integrating hypertension 
and diabetes screening into existing community and clinic 
screening activities is feasible and can increase enrolment 
numbers of  patients in longitudinal care. We employed 
an approach that leverages existing HIV and nutrition 
activities, existing staff  and other resources, and employs 
task-shifting to carry out these pilot screening programmes. 
This approach has also utilised a phased screening approach 
by initially focusing on finding the sickest clients (stage III 
hypertension) in order to avoid overwhelming existing clinics 
and systems with new patients. 
While we increased screening for NCDs and enrolment into 
NCD care, we recognise that much screening and enrolment 
remains to hit the expected number of  hypertensive and 
diabetic individuals in Neno District. We therefore plan to 
expand our screening models to more communities and 
health facilities. By introducing SHARC events in the most 
rural and hard-to-reach communities, we screen patients 
for multiple diseases who may not travel to health facilities. 
Data management, outcomes, and analysis
We designed specific screening registers and forms for all 
3 screening programmes. All data were recorded on paper 
forms, aggregated by support staff  into reports, and entered 
into simple Microsoft Excel databases. We used Excel to 
conduct descriptive statistics on the clients who benefitted 
from the screening and were referred for further evaluation.
Ethical considerations
Since screening programmes were done within our clinical 
programmes and we used aggregated data in our analysis, 
we did not provide informed consent to the participants. We 
obtained approval from the Ministry of  Health and National 
Health Sciences Research Council (protocol number 1216) 
to conduct the study.
Results
SHARC: community-based screening
Between July 2015 and December 2016, 178 community 
screening events were conducted in remote areas of  Neno 
District, with 14,115 individuals screened for various diseases 
(Table 2). Of  these adult SHARC clients in 2016, 58% (n = 
8133) and 29% (n = 4016) were screened for hypertension 
and diabetes, respectively. Among those screened, 9% (n = 
716) and 3% (n = 113) were referred to their nearest IC3 for 
further evaluation of  hypertension and diabetes, respectively.
SHARF: OPD-based screening
SHARF was rolled out gradually, starting in May 2015. At 
the end of  the data collection period, 5 health facilities in 
Neno were conducting SHARF at the OPD. One of  these 
was Dambe Health Centre, a primary health centre where 
SHARF started immediately after the clinic opened in April 
2016. Within the first 6 months of  the health centre opening, 
9691 patients visited the OPD and, of  these, blood pressure 
was taken as a vital sign for 5818 (60%) of  all comers of  all 
ages to the clinics. Among patients eligible for hypertension 
screening (aged ≥ 30 years), 168 were referred to IC3 for 
further assessment. Diabetes screening at SHARF had not 
yet begun during the study period.
IC3: Multi-disease screening at existing HIV/NCD 
clinics
In June 2015, multi-disease screening at IC3 commenced 
in 12 health facilities in Neno (Figure 2). Across 8 facilities 
between August 2015 and November 2016, 17,603 screenings 
took place during routine patient visits, including 11,945 
and 839 screenings for hypertension and diabetes. During 
Table 2: Results from integrated 
community screening (SHARC) 
events from July 2015 to December 
2016 in Neno, Malawi
n (%)
Total adults (≥ 12 












SHARC = Screening for Health and Referral in the 
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years old) screened as the denominator, N = 14,150
Table 2: Results from integrated community 
screening (SHARC) events from July 2015 to 
December 2016 in Neno, Malawi
Figure 2: Increase in case detection: Launch of IC3 and initiation 
of noncommunicable disease screening at IC3 in June 2015
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By ensuring that SHARF is introduced to all OPD facilities 
in Neno, we will drastically increase the amount of  people 
being routinely screened for NCDs and other conditions. 
We anticipate that by ensuring these screening programmes 
reach more people, our case detection and enrolment into 
care will also increase. 
As inadequate staff, infrastructure, and training have been 
reported as challenges to NCD care in Malawi, we anticipated 
the same challenges with the IC3 clinic once the screening 
programmes commenced.8 Initially, we recognised that it 
was not possible to have a screening programme without a 
functioning NCD clinic, so we started the integration of  the 
NCD screening programmes into pre-existing NCD clinics. 
We had a dedicated and trained team of  nurses, clinicians, 
and support staff  responsible for running all NCD clinics in 
Neno. As space for running the clinics is a challenge in some 
health facilities, especially in comparison to the number of  
patients attending the clinics, health centre staff  continued 
to find solutions around NCD infrastructure at the health 
facility level, and we did not havec clinic cancellations due 
to lack of  space. With the help of  PIH, there was a good 
system of  drugs and equipment forecasting, procurement, 
and distribution. We adjusted our equipment and drug needs 
to match the expected patient load and we have minimised 
drug stockouts for NCD care in Neno.
There are many lessons learnt from our experience in Neno 
District. One key limitation is the difficulty of  measuring 
linkage to care from the point of  screening into IC3. This 
would allow us to see whether clients referred at screening 
points seek follow-up care and are enrolled in care. Another 
limitation is our IC3 screening data, since it was captured at 
the visit level, not patient level. Since patients are screened at 
every visit and potentially make several visits a year, they can be 
counted more than once. It is also possible that the IC3 clerks 
may have screened known hypertension or diabetes patients 
and improperly recorded routine patient care measures as 
screening measures. A third limitation comes from initial use 
of  the screening register at OPD for SHARF. Since clerks 
were told to take vital signs, including blood pressure, for all 
clients able to fit the electronic BP cuff, we were not easily 
able to measure proportion referred. Finally, we did not refer 
to IC3 some potential clients with hypertension because of  
the high blood pressure cut-off  point for referral. To address 
the first limitations, we plan to launch an electronic linkage 
to care system that utilises a tablet-based application and bar 
code registration at screening events in 2017. Additionally, 
we plan to capture patient-level screening data at IC3 to 
improve screening quality and data use. We worked with 
clerks to write vital signs in health passport books but only 
recorded blood pressures in the screening register if  clients 
were eligible for hypertension screening. We also launched 
a standardised monthly reporting process and form. As the 
clinics matures and we have better capacity to handle more 
patients, we will be lowering the blood pressure cutoff  point 
gradually.
While the data collected by screening programme staff  are 
reviewed monthly by data officers, we have learnt that a 
high level of  oversight is needed at field events to ensure all 
data are collected at each screening event, and that there is 
a robust feedback loop to support staff  at these clinics. The 
team continues to innovate and find new solutions around 
data collection systems and their application. Next steps 
will include further analyses to fully evaluate the costs and 
benefits of  these integrated screening and service delivery 
programmes, as well as further use of  data to refine screening 
processes and criteria. 
Conclusions
To our knowledge, we are the first district in Malawi 
to document integrated screening programmes at the 
community- and facility-levels for NCDs. This has been 
undertaken within the public health system as part of  routine 
clinical care. Since we did not have dedicated funding for 
NCD screening programmes, we leveraged resources from 
existing programmes to integrate further service delivery. 
The bulk of  the work continues to be done by trained support 
staff, who perform the screening programmes alongside 
their routine duties. In an effort to continue enrolling eligible 
patients, we are continuing to scale up these programmes. 
Our experience has shown that is feasible to conduct NCD 
screening in a rural area of  Malawi.
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